Sugi Predict

Sugi Predict / Compounds / SCHEMBL29482181

SCHEMBL29482181

SCHEMBL29482181

CN(C)c1ccc(P(C(C)(C)C)C(C)(C)C)cc1.[Pd+2]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.50
▸ TSHR P16473 6/20 0.50
▸ ALOX15 P16050 4/20 0.50
▸ HSD17B10 Q99714 4/20 0.50
▸ SLC2A1 P11166 1/20 0.41
▸ MAPK1 P28482 5/20 0.41
▸ CYP3A4 P08684 3/20 0.41
▸ TDP1 Q9NUW8 3/20 0.41
▸ TP53 P04637 2/20 0.41
▸ MAPT P10636 3/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ CYP2A6 P11509 1/20 0.37
▸ CYP2A13 Q16696 1/20 0.37
▸ CHRM5 P08912 1/20 0.36
▸ CHKA P35790 1/20 0.36
▸ HBB P68871 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29789670 1.00 ALDH1A1 (0.50) ALDH1A1TSHRALOX15HSD17B10SLC2A1
Hydrochloric Acid SCHEMBL14485334 0.98 ALDH1A1 (0.48) ALDH1A1TSHRALOX15HSD17B10SLC2A1
Hydrochloric Acid SCHEMBL114430 0.98 ALDH1A1 (0.48) ALDH1A1TSHRALOX15HSD17B10SLC2A1
SCHEMBL616862 0.98 ALDH1A1 (0.52) ALDH1A1TSHRALOX15HSD17B10SLC2A1
Hydrochloric Acid SCHEMBL28840014 0.95 ALDH1A1 (0.50) ALDH1A1TSHRALOX15HSD17B10SLC2A1
Hydrochloric Acid SCHEMBL30670337 0.95 ALDH1A1 (0.50) ALDH1A1TSHRALOX15HSD17B10SLC2A1
Hydrochloric Acid SCHEMBL28153388 0.95 ALDH1A1 (0.50) ALDH1A1TSHRALOX15HSD17B10SLC2A1
SCHEMBL27822750 0.95 ALDH1A1 (0.50) ALDH1A1TSHRALOX15HSD17B10SLC2A1
Hydrochloric Acid SCHEMBL27243769 0.95 ALDH1A1 (0.50) ALDH1A1TSHRALOX15HSD17B10SLC2A1
SCHEMBL9939143 0.95 ALDH1A1 (0.50) ALDH1A1TSHRALOX15HSD17B10SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120004789-A Synthesis method and application of compound containing aryl diacid structure of cyclic fatty tertiary amine 中国科学院化学研究所 2025-05-16 — — CN claimed
EP-4161904-A1 INTERMEDIATES AND PROCESSES FOR THE PREPARATION OF TOLVAPTAN AND ITS DERIVATIVES Cambrex Profarmaco Milano S.r.l. (IT) 2023-04-12 — — EP claimed
CN-115611853-A Hole transport material, preparation method thereof and organic electroluminescent device 北京大学深圳研究生院 2023-01-17 — — CN claimed
US-20250197353-A1 METHOD OF FORMING BOND BY COUPLING REACTION CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2025-06-19 — — US disclosed
CN-120058771-A Aryl silicon modified fluorene organic photoelectric functional material and synthesis method thereof 河南省科学院化学研究所有限公司 2025-05-30 — — CN disclosed
CN-120058770-A Aryl silicon modified spiro organic photoelectric functional material and synthesis method thereof 河南省科学院化学研究所有限公司 2025-05-30 — — CN disclosed
CN-120058723-A Camptothecins compound and its preparation method and application 四川科伦博泰生物医药股份有限公司 2025-05-30 — — CN disclosed
CN-119790056-A Tri-ring derivative, pharmaceutical composition and application 楚浦创制（武汉）医药科技有限公司 2025-04-08 — — CN disclosed
CN-119698417-A Substituted purinone derivatives as ubiquitin-specific protease inhibitors 正大天晴药业集团股份有限公司 2025-03-25 — — CN disclosed
CN-117567478-B Camptothecins compound and its preparation method and application 四川科伦博泰生物医药股份有限公司 2025-03-21 — — CN disclosed
CN-116199656-B Compound containing naphthofuran and anthracene and organic light-emitting device using compound 阜阳欣奕华新材料科技股份有限公司 2025-01-28 — — CN disclosed
CN-118184523-B Diamine compound, intermediate thereof, and polyimide film 天津派森新材料技术有限责任公司 2024-07-26 — — CN disclosed
CN-118184523-A Diamine compound, intermediate thereof, and polyimide film 天津派森新材料技术有限责任公司 2024-06-14 — — CN disclosed
CN-115611853-B Hole transport material, preparation method thereof and organic electroluminescent device 北京大学深圳研究生院 2024-04-16 — — CN disclosed
CN-117886845-A Carbazole compound and organic electroluminescent device comprising carbazole compound 阜阳欣奕华材料科技有限公司 2024-04-16 — — CN disclosed
CN-116969818-A Preparation method of benzene olefin compound and olefine boric acid reagent 上海凌凯医药科技有限公司 2023-10-31 — — CN disclosed
CN-116783160-A Libraries of compounds 中外制药株式会社 2023-09-19 — — CN disclosed
CN-116199656-A Compound containing naphthofuran and anthracene and organic light-emitting device using compound 阜阳欣奕华材料科技有限公司 2023-06-02 — — CN disclosed
CN-115611853-A Hole transport material, preparation method thereof and organic electroluminescent device 北京大学深圳研究生院 2023-01-17 — — CN disclosed
EP-3481814-B1 TETRAHYDRONAPHTHYRIDINEPENTANAMIDE INTEGRIN ANTAGONISTS UNIV ROCKEFELLER (US) 2022-04-27 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250197353-A1 METHOD OF FORMING BOND BY COUPLING REACTION CBR1, CBR3, NOX4 ALDH1A1 1855/4885TSHR 1022/4885ALOX15 1425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.